Wed. 02/12 – The First Big AI Legal Ruling

Feb 12, 2025 16m

AI Summary Available

Get the full experience! Sign up to access transcripts, personalized summaries, and more features.

Episode Description

The first big AI legal ruling has come down, and it might not be good news for AI startups. Apple launches its biggest health study yet. This one weird trick that tech companies are using to make their AI spending seem not so expensive. And Matt Levine on the whole Elon buying OpenAI thing. Sponsors: Kinsta.com/brian FactorMeals.com/ride50off Links: Thomson Reuters Wins First Major AI Copyright Case in the US (Wired) Apple Plans to Learn More About Your Holistic Health With Its New Apple Health Study. You Can Enroll Now (CNET) Meta In Talks To Buy Korean AI Chip Startup Founded By Samsung Engineer (Forbes) Meta Accounting Move on AI Servers to Boost Profit This Year (Bloomberg) Sam Altman Dismisses Elon Musk’s Bid to Buy OpenAI in Letter to Staff (Wired) Sure Elon Musk Might Buy OpenAI (Matt Levine/Bloomberg)

AI-Generated Summary

The First Major AI Legal Ruling

In a landmark ruling, Thomson Reuters won its case against legal AI startup Ross Intelligence for copyright infringement. The court found that Ross used Thomson Reuters' material without permission, marking a significant case in establishing limits around fair use for AI companies. The judge's focus on the intent to compete with Thomson Reuters raises concerns for generative AI platforms, hinting at potential challenges they might face in similar legal situations.

Apple's Comprehensive Health Study Launch

Apple, in collaboration with Brigham and Women's Hospital, has launched a large-scale, voluntary health study. This initiative seeks to analyze various health metrics from iPhone users, exploring connections between technology and overall wellness. The study aims to provide insights that could influence future health-related product developments by Apple.

Meta's Strategic Shift in AI Infrastructure Costs

Meta has made a notable adjustment to how it accounts for depreciation on its AI infrastructure, extending its useful life estimate from four or five years to five and a half. This change is projected to reduce the company’s expenses significantly, showcasing how financial strategies can impact corporate earnings amid heavy investments in AI.

Elon's Potential Bid for OpenAI and Industry Implications

Discussion around Elon Musk's rumored interest in buying OpenAI highlighted confusion and concern within the organization. While Musk's bid could elevate OpenAI’s valuation, it poses ethical questions about the obligations of a nonprofit to maximize asset returns when its mission is to build beneficial AI for humanity. The complexity of OpenAI's goals complicates their response to these potential offers.